Wilms' Tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells

Oncogene

Volumn 12, Issue 3, 1996, Pages 537-546

  Menke, A L ^a   Riteco, N ^a   Van Ham, R C A ^a   De Bruyne, C ^a   Rauscher III, F J ^b   Van Der Eb, A J ^a   Jochemsen, A G ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b WISTAR INSTITUTE   (United States)

Author keywords

Adenovirus; Serum dependency; Tumorigenicity; Wilm's tumor; WT1

Indexed keywords

COMPLEMENTARY DNA; DNA; DNA BINDING PROTEIN; TRANSCRIPTION FACTOR;

ADENOVIRUS; ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CANCER GENETICS; CARCINOGENICITY; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA SEQUENCE; DNA TRANSFECTION; ELECTROPHORETIC MOBILITY; KIDNEY CELL; NEPHROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN VARIANT; STRUCTURE ACTIVITY RELATION; TUMOR GROWTH; VIRUS CELL TRANSFORMATION;

ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CONSENSUS SEQUENCE; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; GENES, WILMS TUMOR; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; OLIGODEOXYRIBONUCLEOTIDES; RATS; RECOMBINANT PROTEINS; TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS; VARIATION (GENETICS); WILMS TUMOR; WT1 PROTEINS; ZINC FINGERS;

ADENOVIRIDAE; ANIMALIA;

EID: 0029670603     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Amin KM, Litzky LA, Smythe WR, Mooney AM, Morris JM, Mews DJY, Pass HI, Kari C, Rodeck U, Rauscher FJ, Kaiser LR and Albelda SM. (1995). Am. J. Pathol., 146, 344-356.
2. Bauer M, Guhl E, Greassmann M and Greassmann A. (1987). J. Virol., 61, 1821-1827.
3. Bernards R, Houweling A, Schrier PI, Bos JL and Van der Eb AJ. (1982). Virology, 120, 422-432.
4. Bickmore WA, Oghene K, Little MH, Seawright A, Van Heyningen V and Hastie ND. (1992). Science, 257, 235-237.
5. Bradford M. (1976). Anal. Biochem., 72, 248-254.
6. Brenner BM. (1990). J. Am. Soc. Nephrol., 1, 127-139.
7. Brenner B, Wildhardt G, Schneider S and Royer-Pokora B. (1992). Oncogene, 7, 1431-1433.
8. Brieger J, Weidmann E, Fenchel K, Mitrou PS, Hoelzer D and Bergmann L. (1994). Leukemia, 8, 2138-2143.
9. Bruening W, Bardeesy N, Silverman BL, Cohn RA and Machin GA. (1992). Nature Genet., 1, 144-148.
10. Bruening W, Gros P, Sato T, Stanimir J, Nakamura Y, Housman D and Pelletier J. (1993). Cancer Invest., 11, 393-399.
11. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C and Housman DE. (1990). Cell, 60, 509-520.
12. Drummond IA, Rupprecht HD, Rohwer-Nutter P, Lopez-Guisa JM, Madden SL, Rauscher III FJ and Sukhatme VP. (1994). Mol. Cell. Biol., 14, 3800-3809.
13. Ekblom P, Miettinen A and Saxen L. (1980). Dev. Biol., 74, 263-274.
14. Gessler M, König A and Bruns GAP. (1992). Genomics, 12, 807-813.
15. Haber DA, Park S, Maheswaran S, Englert C, Re GG, Hazen-Martin DJ, Sens DA and Garvin AJ. (1993). Science, 262, 2057-2059.
16. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM and Housman DE. (1991). Proc. Natl. Acad. Sci. USA, 88, 9618-9622.
17. Harlow E, Franza BR and Schley C. (1985). J. Virology, 34, 533-546.
18. Hastie ND. (1994). Annu. Rev. Genet., 28, 523-558.
19. Köng A, Jacubiczka S, Wieacker P, Schlösser HW and Gessler M. (1993). Hum. Mol. Genet., 2, 1967-1968.
20. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D and Jaenisch R. (1993). Cell, 74, 679-691.
21. Larsson SH, Charlieu J, Miyagawa K, Engelkamp D, Rassoulzadegan M, Ross A, Cuzin F, Van Heyningen V and Hastie ND. (1995). Cell, 81, 1-20.
22. Madden SL, Cook DM, Morris JF, Gashler A, Sukhatme VP and Rauscher III FJ. (1991). Science, 253, 1550-1553.
23. Madden SL, Cook DM and Rauscher III FJ. (1993). Oncogene, 8, 1713-1720.
24. Maheswaran S, Park S, Bernard A, Morris JF, Rauscher III FJ, Hill DE and Haber DA. (1993). Proc. Natl. Acad. Sci. USA, 90, 5100-5104.
25. Menke AL, Van Ham RCA, Sonneveld E, Shvarts A, Stanbridge EJ, Miyagawa K, Van der Eb AJ and Jochemsen AG. (1995). Int. J. Cancer, 63, 76-85.
26. Menssen HD, Renkl HJ, Rodeck U, Maurer J, Notter M, Schwartz S, Reinhardt R and Thiel E. (1995). Leukemia, 9, 1060-1067.
27. Miwa H, Beran M and Saunders GF. (1992). Leukemia, 6, 405-409.
28. Morris JF, Madden SL, Tournay OE, Cook DM, Sukhatme VP and Rauscher FJ. (1991). Oncogene, 6, 2339-2348.
29. Nakagama H, Heinrich G, Pelletier J and Housman DE. (1995). Mol. Cell. Biol., 15, 1489-1498.
30. Pritchard-Jones K and Flemming S. (1991). Oncogene, 6, 2211-2220.
31. Pritchard-Jones K, Flemming S, Davidson D, Bickmore W, Porteous D, Gosden C, Bard J, Buckler A, Pelletier J, Housman D, Van Heyningen V and Hastie N. (1990). Nature, 346, 194-197.
32. Rauscher III FJ. (1993). FASEB J., 7, 896-903.
33. Rauscher III FJ, Morris JF, Tournay OE, Cook DM, Curran T. (1990). Science, 250, 1259-1262.
34. Reddy JC, Morris JC, Wang J, English MA, Haber DA, Shi Y and Licht JD. (1995). J. Biol. Chem., 270, 10878-10884.
35. Rodeck U, Bossler A, Kari C, Humphreys CW, Gyorfi T, Maurer J, Thiel E and Menssen HD. (1994). Int. J. Cancer, 59, 78-82.
36. Rupprecht HD, Drummond IA, Madden SL, Rauscher III FJ and Sukhatme VP. (1994). J. Biol. Chem., 269, 6198-6206.
37. Sabattini P, Chiou S-K, Rao L and White E. (1995). Mol. Cell. Biol., 15, 1060-1070.
38. Sharma PM, Yang X, Bowman M, Roberts V and Sukumar S. (1992). Cancer Research, 52, 6407-6412.
39. Steegenga WT, Van Laar T, Shvarts A, Terleth C, Van der Eb AJ and Jochemsen AG. (1995). Virology, 212, 543-554.
40. Stewart CL, Stuhlmann H, Jahner D and Jaenisch R. (1982). Proc. Natl. Acad. Sci. USA, 79, 4098-4102.
41. Van den Heuvel SJL, Van Laar T, The I and Van der Eb AJ. (1993). J. Virology, 67, 5226-5234.
42. Van Leer EHG, De Roo GM, Hoedemaker PJ and De Heer E. (1993) Exp. Nephrol., 1, 292-300.
43. Walker C, Rutten F, Yuan X, Pass H, Mew DM and Everitt J. (1994). Cancer Research, 54, 3101-3106.
44. Wang Z, Qiu Q, Huang J, Gurrieri M and Deuel TF. (1995a). Oncogene, 10, 415-422.
45. Wang Z, Qiu Q, Gurrieri M, Huang J and Deuel TF. (1995b). Oncogene, 10, 1243-1247.
46. Yew PR and Berk AJ. (1992). Nature, 357, 82-85.
47. Zantema A, Schrier PI, Davis-Olivier A, Van Laar T, Vaessen RTMJ and Van der Eb AJ. (1985). Mol. Cell. Biol., 5, 3084-3091.
48. Zhou Y, Li J, Xu K, Hu S-X, Benedict WF and Xu H-J. (1994). Proc. Natl. Acad. Sci. USA, 91, 4165-4169.